Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study

BMC Urology ◽

10.1186/s12894-016-0193-z ◽

2017 ◽

Vol 17 (1) ◽

Author(s):

Hao Wang ◽

Lucille J. Russell ◽

Kathleen M. Kelly ◽

Steven Wang ◽

John Thipphawong

Keyword(s):

Interstitial Cystitis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Controlled Study ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

Pentosan Polysulfate Sodium for Treatment of Interstitial Cystitis/Bladder Pain Syndrome: Insights from a Randomized, Double-Blind, Placebo Controlled Study

The Journal of Urology ◽

10.1016/j.juro.2014.09.036 ◽

2015 ◽

Vol 193 (3) ◽

pp. 857-862 ◽

Author(s):

J. Curtis Nickel ◽

Sender Herschorn ◽

Kristene E. Whitmore ◽

John B. Forrest ◽

Peter Hu ◽

...

Keyword(s):

Interstitial Cystitis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Controlled Study ◽

Pentosan Polysulfate ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

578 The efficacy of intravesical onabotulinumtoxin-A injection in the treatment of interstitial cystitis/bladder pain syndrome: A randomized, double-blind, placebo controlled study

European Urology Supplements ◽

10.1016/s1569-9056(14)60569-8 ◽

2014 ◽

Vol 13 (1) ◽

pp. e578-e578b ◽

Author(s):

C-L. Lee ◽

Y-H. Jiang ◽

J-F. Jhang ◽

H-C. Kuo

Keyword(s):

Interstitial Cystitis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Controlled Study ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo ◽

Onabotulinumtoxin A

Download Full-text

Faculty of 1000 evaluation for A Randomized, Double-Blind, Placebo Controlled Trial of Adalimumab in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718022125.793480106 ◽

2013 ◽

Author(s):

Altaf Mangera

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

PD01-01 RESULTS FROM A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE EFFICACY AND SAFETY OF INTRA-TRIGONAL INJECTION OF ONABOTULINUM TOXIN A IN PATIENTS WITH BLADDER PAIN SYNDROME/INTERSTITIAL CYSTITIS.

The Journal of Urology ◽

10.1016/j.juro.2017.02.181 ◽

2017 ◽

Vol 197 (4S) ◽

Author(s):

Rui Pinto ◽

Daniel Costa ◽

Afonso Morgado ◽

Pedro Pereira ◽

João Silva ◽

...

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Efficacy And Safety ◽

Toxin A ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo ◽

Onabotulinum Toxin A

Download Full-text

PD9-11 A RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED TRIAL OF ADALIMUMAB IN THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

The Journal of Urology ◽

10.1016/j.juro.2014.02.793 ◽

2014 ◽

Vol 191 (4S) ◽

Author(s):

Philip Bosch

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

821 A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE IIA TRIAL OF A CA 2+ CHANNEL α2Δ LIGAND, PD-0299685, FOR THE TREATMENT OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME

The Journal of Urology ◽

10.1016/j.juro.2012.02.911 ◽

2012 ◽

Vol 187 (4S) ◽

Author(s):

J. Curtis Nickel ◽

Anna Crossland ◽

Edward Davis ◽

Francois Haab ◽

Ian Mills ◽

...

Keyword(s):

Interstitial Cystitis ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome

European Urology ◽

10.1016/j.eururo.2018.07.026 ◽

2018 ◽

Vol 74 (5) ◽

pp. 623-630 ◽

Author(s):

Philip C. Bosch

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of A randomized, double-blind, placebo controlled trial of adalimumab for interstitial cystitis/bladder pain syndrome.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718022125.793482012 ◽

2013 ◽

Author(s):

Francisco Cruz

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

Re: A Randomized, Double-blind, Placebo-controlled Trial of Certolizumab Pegol in Women with Refractory Interstitial Cystitis/Bladder Pain Syndrome

European Urology ◽

10.1016/j.eururo.2018.10.050 ◽

2019 ◽

Vol 75 (3) ◽

pp. 534

Author(s):

Piotr Radziszewski ◽

Łukasz Zapała

Keyword(s):

Interstitial Cystitis ◽

Controlled Trial ◽

Certolizumab Pegol ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Double Blind ◽

Bladder Pain ◽

Double Blind Placebo

Download Full-text

Safety and efficacy of pentosan polysulfate in patients with bladder pain syndrome/interstitial cystitis: a multicenter, double–blind, placebo–controlled, randomized study

Central European Journal of Urology ◽

10.5173/ceju.2021.0340.r1 ◽

2021 ◽

Vol 74 (2) ◽

Keyword(s):

Interstitial Cystitis ◽

Randomized Study ◽

Pain Syndrome ◽

Bladder Pain Syndrome ◽

Pentosan Polysulfate ◽

Double Blind ◽

Bladder Pain ◽

Safety And Efficacy ◽

Double Blind Placebo

Download Full-text